BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Business

  Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments

  Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company) today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided a review of recent accomplishments and anticipated upcoming developments.

  February 29, 2024

   · 

  28 min read
• Business

  Quantum-Si Reports Fourth Quarter and Full Year 2023 Financial Results

  Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced financial results for the fourth quarter and full year ended December 31, 2023.

  February 29, 2024

   · 

  13 min read
• Bio NC

  Precision BioSciences Announces Proposed Public Offering of Common Stock and Warrants

  Precision BioSciences, Inc. announced the commencement of a proposed underwritten public offering of its common stock and accompanying warrants to purchase shares of common stock, including pre-funded warrants to purchase common stock in lieu of common stock for certain purchasers.

  February 29, 2024

   · 

  4 min read
• Business

  Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023

  Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced financial results for the fourth quarter and twelve months ended December 31, 2023.

  February 29, 2024

   · 

  12 min read
• Business

  Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

  Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided a business update.

  February 29, 2024

   · 

  8 min read
• Business

  GENFIT Announces Revenues and Cash Position as of December 31, 2023

  GENFIT, a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, announced its cash position as of December 31, 2023 and revenues for 2023.

  February 29, 2024

   · 

  8 min read
• Business

  RadNet Reports Fourth Quarter 2023 Results, Including Record Revenue and Adjusted EBITDA(1), Releases 2024 Financial Guidance and Forms a New Digital Health Reporting Segment

  RadNet, Inc. reported financial results for its fourth quarter and full year ended December 31, 2023.

  February 29, 2024

   · 

  36 min read
• BioForest

  Know Labs Secures U.S. $12 Million Funding for Company’s Further Execution on Its Clinical Research and Development Initiatives

  Know Labs, Inc. announced it has entered into a funding agreement for an investment of up to $12 million, of which it has executed a $4 million close with Lind Global Fund II LP, an investment entity managed by The Lind Partners, a New York-based institutional fund manager.

  February 29, 2024

   · 

  7 min read
• BioMidwest

  CENTENE TO PRESENT AT BARCLAYS 26TH ANNUAL GLOBAL HEALTHCARE CONFERENCE

  Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today it will present at the Barclays 26th Annual Global Healthcare Conference, to be held Tuesday, March 12 – Thursday, March 14, 2024, in Miami, Florida.

  February 29, 2024

   · 

  1 min read